A Phase 2, Double-blind Study of S-005151 in Patients with Acute Ischemic Stroke
Latest Information Update: 12 Apr 2023
At a glance
- Drugs Redasemtide (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Sponsors Shionogi
- 10 Apr 2023 Results presented in the Shionogi Media Release.
- 22 Sep 2022 Status changed from recruiting to completed.
- 15 Jul 2020 New trial record